RxDoctor Payments Data

Jennifer Nayak

Pediatric Infectious Diseases · Rochester, NYNPI 1326054883

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Merck. That places this record below the midpoint for pediatric infectious diseases clinicians in NY, where the typical reported total is $248.

$28in general payments, 2019–2025

Across 1 payment — averaging $27.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$28
$1,801,916in research payments, 2019–2025

Across 172 payments — averaging $10,476 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$914K
  • Merck$706K
  • Sanofi Pasteur Inc.$98K
  • Modernatx, Inc.$84K

What the payments were for

  • Food & beverage$28100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck1$28

How this compares

$28 in reported general payments places this provider in the 20th percentile of 73 pediatric infectious diseases providers in New York.

See all pediatric infectious diseases providers in New York →

Other pediatric infectious diseases in Rochester

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →